These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32210362)

  • 1. Exploring metabolic adaptation of Streptococcus pneumoniae to antibiotics.
    Leonard A; Möhlis K; Schlüter R; Taylor E; Lalk M; Methling K
    J Antibiot (Tokyo); 2020 Jul; 73(7):441-454. PubMed ID: 32210362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic inventory of Streptococcus pneumoniae growing in a chemical defined environment.
    Leonard A; Gierok P; Methling K; Gómez-Mejia A; Hammerschmidt S; Lalk M
    Int J Med Microbiol; 2018 Aug; 308(6):705-712. PubMed ID: 29398251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection and metabolism - Streptococcus pneumoniae metabolism facing the host environment.
    Leonard A; Lalk M
    Cytokine; 2018 Dec; 112():75-86. PubMed ID: 30077545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.
    Rodríguez-Cerrato V; García P; Del Prado G; García E; Gracia M; Huelves L; Ponte C; López R; Soriano F
    J Antimicrob Chemother; 2007 Nov; 60(5):1159-62. PubMed ID: 17827138
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Burcham LR; Hill RA; Caulkins RC; Emerson JP; Nanduri B; Rosch JW; Fitzkee NC; Thornton JA
    Metallomics; 2020 Sep; 12(9):1416-1427. PubMed ID: 32676626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated proteomic and metabolomic analysis reveals that rhodomyrtone reduces the capsule in Streptococcus pneumoniae.
    Mitsuwan W; Olaya-Abril A; Calderón-Santiago M; Jiménez-Munguía I; González-Reyes JA; Priego-Capote F; Voravuthikunchai SP; Rodríguez-Ortega MJ
    Sci Rep; 2017 Jun; 7(1):2715. PubMed ID: 28578394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of antibiotics with various target sites on the metabolome of Staphylococcus aureus.
    Dörries K; Schlueter R; Lalk M
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7151-63. PubMed ID: 25224006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtractive genome analysis for in silico identification and characterization of novel drug targets in Streptococcus pneumonia strain JJA.
    Wadood A; Jamal A; Riaz M; Khan A; Uddin R; Jelani M; Azam SS
    Microb Pathog; 2018 Feb; 115():194-198. PubMed ID: 29277475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia.
    Alou L; Giménez MJ; Sevillano D; Aguilar L; Cafini F; Echeverría O; Pérez-Trallero E; Prieto J
    J Antimicrob Chemother; 2006 Aug; 58(2):349-58. PubMed ID: 16782744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and prediction of the mechanism of action of antibiotics through NMR metabolomics.
    Hoerr V; Duggan GE; Zbytnuik L; Poon KK; Große C; Neugebauer U; Methling K; Löffler B; Vogel HJ
    BMC Microbiol; 2016 May; 16():82. PubMed ID: 27159970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014].
    Sun H; Chen L; Chen X; Jia X; Li N; Liu W; Tong H; Xiang R; Zhang F; Zhao H; Zhang J; Xu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jan; 39(1):30-7. PubMed ID: 26792053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiome-related metabolic changes in plasma of antibiotic-treated rats.
    Behr C; Kamp H; Fabian E; Krennrich G; Mellert W; Peter E; Strauss V; Walk T; Rietjens IMCM; van Ravenzwaay B
    Arch Toxicol; 2017 Oct; 91(10):3439-3454. PubMed ID: 28337503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined metabolomic and correlation networks analyses reveal fumarase insufficiency altered amino acid metabolism.
    Hou E; Li X; Liu Z; Zhang F; Tian Z
    Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29130499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing trends in antimicrobial susceptibility of Streptococcus pneumoniae isolates in Taiwan, 2006-2007.
    Li CF; Liu MF; Shi ZY; Hsueh PR; Liao CH; Jang TN; Tsao SM; Kung HC; Hsu GJ; Cheng YJ; Lin HC; Liu YC; Chuang YC; Wang LS; Chen CM
    J Microbiol Immunol Infect; 2012 Aug; 45(4):305-10. PubMed ID: 22608926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal activities of parenteral antibiotics and genotype of penicillin-binding protein in Streptococcus pneumoniae and Haemophilus influenzae isolated from children's blood.
    Sakata H
    J Infect Chemother; 2006 Oct; 12(5):338-42. PubMed ID: 17109098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
    Heffelfinger JD; Dowell SF; Jorgensen JH; Klugman KP; Mabry LR; Musher DM; Plouffe JF; Rakowsky A; Schuchat A; Whitney CG
    Arch Intern Med; 2000 May; 160(10):1399-408. PubMed ID: 10826451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in antibiotic-induced oxidative stress responses between laboratory and clinical isolates of Streptococcus pneumoniae.
    Dridi B; Lupien A; Bergeron MG; Leprohon P; Ouellette M
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5420-6. PubMed ID: 26100702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of Macrolide-Induced Inhibition of Pneumolysin Release Involves Impairment of Autolysin Release in Macrolide-Resistant Streptococcus pneumoniae.
    Domon H; Maekawa T; Yonezawa D; Nagai K; Oda M; Yanagihara K; Terao Y
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181369
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.